











1Trends in Quality-Adjusted Life-Years
Lost Contributed by Smoking
and Obesity
Haomiao Jia, PhD, Erica I. Lubetkin, MD, MPH
Background: Quality-adjusted life-years (QALYs) use preference-based measurements of health-
related quality-of-life (HRQOL) to provide an assessment of the overall burden of disease using a
single number.
Purpose: This study estimatedQALYs lost contributed by smoking and obesity forU.S. adults from
1993 to 2008.
Methods: Population HRQOL data were from the 1993–2008 Behavioral Risk Factor Surveillance
System. TheQALYs lost contributed by a risk factor is the sum ofQALYs lost due tomorbidity in the
current year and future QALYs lost in expected life-years due to premature deaths (mortality).
Premature deaths were estimated from the National Health Interview Survey LinkedMortality Files
and mortality statistics.
Results: From 1993 to 2008, the proportion of smokers among U.S. adults declined 18.5% whereas
the proportion of obese people increased 85%. The smoking-relatedQALYs lost were relatively stable
at 0.0438 QALYs lost per population. In 1993 the QALYs lost were much smaller for obesity
compared to smoking, with obesity contributing about 0.0204QALYs lost.However, as a result of the
increasing prevalence of obesity, the contribution of obesity-related QALYs lost increased consis-
tently and had increased by 127% in 2008 when obesity resulted in 0.0464 QALYs lost, slightly more
than smoking did. Smoking had a bigger impact on mortality than morbidity, whereas obesity had a
bigger impact on morbidity than mortality.
Conclusions: This study estimated the overall burden of smoking and obesity over time and
results indicate that because of the marked increase in the proportion of obese people, obesity
has become an equal, if not greater, contributor to the burden of disease than smoking. Such data
are essential in setting targets for reducing modifıable health risks and eliminating health
disparities.
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38 Am J Prev Med 2010;38(2):138–144 © 2010 Amern the overall burden of disease (associated with a partic-
lar risk factor, determinant, disease or injury), the de-
ree to which the burden can be prevented or reduced,
nd the cost effectiveness of alternative opportunities to
educe the health burden. In analyzing the health impact
f risk factors, mortality or morbidity statistics such as
ttributable mortality and health-related quality of life
HRQOL) commonly have been used as outcome mea-
ures.2 However, as noted by the Secretary’s Advisory
ommittee, a single measurement such as the quality-
djusted life-year (QALY) would be particularly useful in
uantifying the overall health impact of risk factors using
ne number.1,3
Quality-adjusted life-years use preference-based mea-
urements of health-related quality of life (HQROL) to
rovide an assessment of the overall burden of diseases as-
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Fociated with both mortality and morbidity.4 Preference-
ased HRQOL measures use summary scores (i.e., utility
alues) to represent population preferences for different
ealth states. Thus, 1 year of life lived at a utility score of 0.8
s equal to 0.8QALY. The totalQALYs lost contributed by a
isk factor includes the QALYs lost due to nonfatal diseases
morbidity) in the current year and the futureQALYs lost in
he expected life-years as a result of premature deaths
mortality).5–7
Burden of disease and cost-effectiveness analyses are
specially useful for quantifying the impact of particular
odifıable risk factors, analyzing disparities in QALYs
oth at the national and local (community) levels and
or small sociodemographic subgroups, and examining
hanges over time. However, prior to Year 2000 these anal-
ses were not able to be conducted in the U.S. because of
he lack of a data set that contained health utility scores
or a representative sample of thepopulation.During2000–
003, the Medical Expenditure Panel Survey (MEPS) in-
luded the EQ-5D, a QALY-compatible and preference-
ased instrument.8 Using EQ-5D scores from the 2000
EPS, an estimate has been made of the burden of dis-
ase attributable to obesity/overweight and low income in
he general U.S. population.5,6 However, because the
EPS included the EQ-5D between 2000 and 2003 only
nd was designed to provide information for the entire
ation—and not for individual states or at the local
evel—trends over time and geographic variations were
nable to be examined.
This study examined the trend of the health burden of
moking and obesity for U.S. adults from 1993 to 2008
sing currently available population-based data. These
wo modifıable risk factors have the greatest impact on
orbidity and mortality in the U.S.9,10 The total QALYs
ost were the sum of the QALYs lost due to a decrease in
RQOL score (morbidity) and the future QALYs lost in
he expected life-years due to premature deaths (mortal-
ty) contributed by these two modifıable risk factors. The
roposed method also can be used for examining health
isparities and evaluating progress at the national, state,
nd local levels with regard to the upcoming Healthy
eople 2020 health objectives.
aterials and Methods
ata and Measurements
opulation HRQOL data were from the 1993–2008 Be-
avioral Risk Factor Surveillance System (BRFSS), the
argest ongoing state-based health survey of U.S.
dults.11,12 The BRFSS is a random-digit-dialed telephone
urvey that interviews non-institutionalized civilian adult
esidents aged18 years to collect health-related data at the
tate and substate levels and to track trends over time.11,12 In t
ebruary 2010his analysis, N3,590,540; the annual n ranged from
02,263 in 1993 to 406,749 in 2008.
Since 1993, the BRFSS has included a set of questions for
ecent poor health days to describe and track the overall phys-
cal andmental health of populations.13 Thesemeasures, called
he Healthy Days, ask respondents about the number of phys-
cally unhealthy days, mentally unhealthy days, and days with
ctivity limitation during the past 30 days. The CDC also rec-
mmends constructing a summary measure of overall un-
ealthydaysbyaddingphysically andmentallyunhealthydays,
ith a logicalmaximumof 30 unhealthy days.14 Because of the
bsence of other temporal and spatial data thatmeasure popu-
ation HRQOL, the CDC has promoted the BRFSS as being
apable of fılling an important data void.12
However, because the numbers of poor health days are not
reference-based measures of HRQOL, the measures cannot
e used to calculate QALYs for burden of disease and cost-
ffectiveness analyses directly.14,15 Recognizing this limitation,
heHRQOLSurveillance Expert Panel convened by theCDC’s
ivision of Adult and Community Health recommended cali-
rating HRQOL scores to preference-based measures.16 Sev-
ral studies have examined the possibility for a statistical cross-
alk between theHealthyDays andutility scores ofHRQOL to
evelop multivariable conversion tables for formulas to esti-
ate utility scores from unhealthy days.14,15
Apreviously constructed formulawasusedhere for estimat-
ngEQ-5D index scores fromtheHealthyDaysmeasures to the
RFSS respondents.15 The respondents’ EQ-5D scores were
stimated based on their number of overall unhealthy days,
elf-ratedhealth status, andagecategory.Thevalidationstudies
emonstrated that the estimatingmodel fıt data well17 and the
stimated EQ-5D index score had acceptable validity in terms
f providing accurate estimated mean scores in different sub-
roups needed for calculating QALYs.15
The National Center for Health Statistics produced the
ational Health Interview Survey (NHIS) Linked Mortality
iles by linking eligible adults in the NHIS data to the Na-
ional Death Index to obtain mortality follow-up through
ecember 31, 2002.18 The NHIS contains sociodemograph-
cs and health behavior questions similar to the BRFSS. The
997–2000 cohort of theNHIS LinkedMortality File and the
etailed mortality data compiled by the CDC19 were used to
stimate premature deaths due to each risk factor.
The hazard ratios for smoking (current smokers versus
ot) and obesity (BMI30 kg/m2 vs 18.5–30 kg/m2) were
stimated from the NHIS Linked Mortality File data. The
moking- and obesity-associated excess death rate in each





here Hi is the estimated hazard ratio at age i, mi is the
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he detailed mortality data (by age and gender) also were
sed to construct life tables (in 1-year intervals) to calcu-
ate life expectancy at age i.20 Let Ai be the number of
he population surviving to age i and mi be the mortality
ate for age i. Suppose those who died during the 1-year
nterval lived 0.5 year on average, the total Life Year Bi
etween ages i and i  1 is 1  mi ⁄2Ai. The life
xpectancy at age i, LEi, is total life years above age i
ivided by the number of the population surviving to age
or LEi  ji Bj ⁄Ai. Because the QALYs between ages
and i  1 is Bixi5,6, the QALE at age i is
QALEi ji Bjxj ⁄Ai ,
here xj is the mean EQ-5D index score for the age interval.
uality-Adjusted Life-Years
he total QALYs lost contributed by a risk factor is the sum of
heQALYs lost in 1 year due to a decrease in theHRQOL score
morbidity) and the future QALYs lost in the expected life-
ears due to premature deaths or mortality.5–8 This analysis
sed the proportion of the population to calculate QALYs,
hich canbe converted to totalQALYsbymultiplyingwith the
dult population in each year.
The QALYs lost due to
orbidity contributed by a
isk factor is defıned as the
otential annual QALYs
hat would be gained if
hose at risk had a mean
Q-5D index score thatwas










Q-5D index scores for the
ge interval of the reference
roup and at-risk group,
espectively.
The future QALYs lost
n the expected life-years
ue to excess death is the
roduct of excess deaths
nd the potential QALE





1)pj ⁄ Ai .
he total QALYs lost is




















bEstimated from the BRFSSALYL  morb  mort. cEstimated from the NHIS Linked Moesults
hisanalysisfırstexaminedboththemeanEQ-5Dindexscores
ccording to obesity and smoking status and the hazard ratio
or these two risk factors to analyze the impact of obesity
nd smoking on HRQOL (morbidity) and premature deaths
mortality), respectively (Table 1). Mean EQ-5D scores were
.05 points lower for obese people compared to non-
bese people (0.833 vs 0.883), and such a differencewasmuch
reater (about 51% higher) than the mean score difference
etween smokers and nonsmokers (0.846 vs 0.879 or 0.033
oints difference). However, the estimated hazard ratio for
mokerswasmore than twice thehazard ratio forobesepeople
2.789 vs 1.259), indicating amuch larger impact onmortality
romsmoking than fromobesity.
Next is the annual life expectancy and HRQOL scores
or U.S. adults (Figure 1). Although the life expectancy of
person aged 18 years had increased consistently from
993 to 2008 by approximately 3.5% (from 58.4 years to
0.4 years), the HRQOL of the U.S. adult population had
eclined during the same time period. Mean EQ-5D in-
ex scores decreased from 0.883 to 0.864, or by approxi-
ately 2.2%, and such a decline in EQ-5D scores was
ound in every age and gender subgroup. With the com-
ination of a longer life expectancy but worsening
associated mean EQ-5D scores and hazard ratio by age
Smoke Do not smoke Obese Not obesea
0.846 0.879 0.833 0.883
0.893 0.935 0.905 0.928
0.864 0.913 0.870 0.909
0.809 0.860 0.805 0.866
0.799 0.831 0.782 0.841
0.753 0.773 0.732 0.781
2.789 — 1.259 —
1.075 — 0.576 —
2.269 — 1.348 —
2.094 — 1.074 —
2.325 — 1.241 —
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FRQOL scores, the quality-adjusted life expectancy for a
erson aged 18 years increased slightly from 50.9 years to
1.7 years, or by approximately 1.7%.
The proportion of smokers amongU.S. adults declined
pproximately 18.5%, from 22.7% in 1993 to 18.5% in
008 (Figure 2). However, most of the decline occurred
fter 2002. By contrast, the proportion of obese people
ncreased greatly, from 14.5% to 26.7%, or an 85% in-
rease, and the increase was consistent during this time
eriod. During these 16 years, the total QALYs lost con-
ributed by smoking was relatively stable (standard devi-
nce0.1%), at an average of 0.0438QALYs lost per adult
opulation in each year or 16.0 days of healthy life lost per
dult population. For obesity, the total QALYs lost was
uch smaller in 1993, at 0.0204 QALYs lost per adult
opulation or 7.5 days of healthy life lost per adult popu-
ation. This number was approximately 47% of the
ALYs lost contributed by smoking. However, QALYs
ost contributed by obesity increased by 127% and con-
istently increased with the increase in the percentage of
besity from 1993 to 2008. In 2008, obesity resulted in
.0464 QALYs lost per adult population which slightly
xceeded the number of QALYs lost due to smoking.
The fınal analysis examined the total QALYs lost due
o morbidity and due to mortality separately (Figure
). The greatest number of QALYs lost was due to
moking-related mortality whereas smoking-related
orbidity accounted for the least QALYs lost. For
moking, the QALYs lost due to morbidity increased
rom 0.0083 QALYs lost per adult population in 1993
o 0.0105 QALYs lost per adult population in 2008, or a
igure 1. EQ-5D index, life expectancy at age 18 years (LE
t 18), and quality-adjusted life expectancy at age 18
ears (QALE 18) from 1993 to 2008
Q-5D is a standardized instrument for use as a measure
f health outcome. Applicable to a wide range of health
onditions and treatments, it provides a simple descrip-
ive profile and a single index value for health status. s
ebruary 20106% increase, but the QALYs lost due to mortality de-
reased slightly from 0.0363 to 0.0333 QALYs lost per
dult population, or an 8.4% decrease during this period.
or obesity, both the QALYs lost due to mortality and
hat due to morbidity increased. The QALYs lost due to
orbidity increased 141% (from 0.011 to 0.0265 QALYs
ost per adult population), whereas theQALYs lost due to
ortality increased 112% (from 0.0094 to 0.0199 QALYs
ost per adult population). These results are consistent
ith the fındings reported in Table 1 (i.e., smoking is
ssociatedwithmore premature deathswhereas obesity is
ssociated with a greater negative impact on HRQOL).
iscussion
he overall health burden of obesity among U.S. adults
as increased consistently since 1993. The fınding that
igure 2. Quality-adjusted life-years lost per adult contrib-
ted by obesity and smoking, the obesity rate, and the
moking rate from 1993 to 2008
igure 3. Quality-adjusted life-years lost per adult due to



































































































142 Jia and Lubetkin / Am J Prev Med 2010;38(2):138–144besity is becoming an equal, if not greater, contributor
o the burden of disease as smoking is consistent with the
atterns noted in the profıle of the leading causes of
eath.9,21,22 The substantial increase in the QALYs lost
ontributed by obesity was due to the dramatic increase
n the prevalence of obesity in the U.S.23 By the fınal year
xamined (2008), the total health burden of obesity sur-
assed the total health impact of smoking.
Although the percentage of U.S. adults who are
mokers has decreased since 2002, the burden contrib-
ted by smoking has remained stable. This may be
ue to the differences in peak prevalence of smoking
nd differences in susceptibility to smoking-associated
onditions among subgroups of the population.24
ontinued monitoring of the percentage of smokers
nd burden of disease is crucial, given the recent increase
n the federal cigarette tax and the economic recession.25
Although life expectancy and QALE have increased
ver time, the increase in the contribution of mortality
o QALYs lost from obesity may result in a decline in
uture life expectancy.26 With regard to HRQOL trends,
RQOL has declined during the period examined, and
uch a pattern is consistent with fındings from other
nvestigators in the U.S. and abroad.27–30 Indeed, the
ncreasing contribution of morbidity to QALYs lost due
o obesitymay have accounted for a portion of the decline
f HRQOL.
Previous analyses by theCDChad used the BRFSS data
o estimate premature deaths due to smoking by calculat-
ng the smoking-attributable mortality and the years of
otential life lost (YPLL) for the U.S. states and the Dis-
rict of Columbia from2000 to 2004.31 The interpretation
f YPLL from smoking is similar to theQALYs lost due to
he mortality attributed to smoking, and these two mea-
ures are highly correlated (r0.81). Other analyses ex-
mined the decreases in HRQOL scores for smokers and
bese people32,33 as well as decreases in HRQOL scores
ue to diseases/conditions aligned with smoking and
besity, such as COPD and diabetes.34,35 Unlike these
tudies, a single measurement of QALYs was used in the
urrent study for the overall health impact of smoking
nd obesity, thereby accounting for the effect on both
ortality and morbidity.
Using a single value of QALYs to quantify the burden
f disease enables the direct comparison of economic
osts due to premature deaths and nonfatal disease con-
ributed by a risk factor. With the calculation of QALYs
ost due to morbidity and mortality, smoking has a
reater burden from premature deaths than from disabil-
ty and activity limitations, with the odds of the burden
rommortality and morbidity being 3.4 to 1. By contrast,
besity causes greater burden from disability and activity
imitations than from premature deaths, and the odds sue to morbidity and mortality has been approximately
.3 to 1.
There are several limitations in this analysis. First,
he analysis relies on the validity of EQ-5D estimates
rom the Healthy Days measures. Different measures
f HROQL may not reliably crosswalk among the full
ange of health states at the individual level.14,15 For
xample, because all model-based estimates tend to “re-
ress toward the mean,” this analysis might underesti-
ate the total QALYs lost. Therefore, these calculations
ould likely undervalue the total health impact of smok-
ng and obesity. However, estimated EQ-5D scores
hould have acceptable accuracy in terms of providing
stimated mean scores in different subgroups needed for
alculating QALYs.15,36 Second, the calculated CI of
ALYs would be artifıcially too small and diffıcult to
nterpret because the scores used in this analysis were
ased on the model-estimated EQ-5D scores, not the
ctual observed EQ-5D scores. Also, because the model
ould underestimate EQ-5D scores of people with good
ealth and overestimate scores for people with poor
ealth, the estimated QALYs would be biased. Interpre-
ation of CIs for biased estimates is diffıcult.37,38 There-
ore, CIs and SEs are not reported. Third, in 2002, 28
tates and the District of Columbia did not ask the
ealthy Days questions. This may partially explain the
utliers in the mean estimated EQ-5D index score in
002. The estimated values for 2002 should be for only the
2 states that administrated these questions. Finally,
RFSS data are self-reported, and participants may have
nder- or over-estimated responses to certain items.Data
how that participants tend to under-report both smok-
ng and weight39,40 and, therefore, the burden of disease
ue to both smoking and obesity might actually be
igher.
onclusion
his study proposes a method that uses large, currently
xisting data sets representative of the U.S. general adult
opulation to calculate QALYs lost contributed by two
odifıable risk factors between 1993 and 2008. This
ethod is well timed with the HRQOL Surveillance Ex-
ert Panel’s goal that relates HRQOL surveillance to the
ealthy People 2020 initiative.14 Resultant data might
ssist in the construction of specifıed quantitative targets
or the Healthy People 2020 health objectives and setting
riorities for prevention in a given population as well as
ccording to sociodemographic subgroups.41 This
ethod can be particularly useful when examining the
ealth impact of some modifıable risk factors over time
nd at the local level (such as U.S. states and some sub-
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Fffectiveness analyses. The proposed method takes the
dvantages of the richness of the BRFSS data for the
racking of population health outcomes and provides
ata that are necessary for examining the economic costs
f modifıable risk factors. Although adding an intact,
alidated preference-basedmeasure such as the EQ-5D to
he Healthy Days measures might be a better long-term
olution, trend data would not be available for a number
f years.
o fınancial disclosures were reported by the authors of
his paper.
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